AL Amyloidosis
Showing 26 - 38 of 38
AL Amyloidosis Trial in Boston (Pomalidomide, Dexamethasone)
Completed
- AL Amyloidosis
-
Boston, MassachusettsBoston Medical Center
Sep 3, 2020
AL Amyloidosis Trial in Boston (Venetoclax, Dexamethasone)
Terminated
- AL Amyloidosis
-
Boston, MassachusettsTufts Medical Center
Aug 19, 2020
AL Amyloidosis Trial in Boston, Detroit, New York (Bendamustine, Dexamethasone)
Completed
- AL Amyloidosis
-
Boston, Massachusetts
- +5 more
Mar 17, 2020
AL Amyloidosis, Amyloidosis Trial in South San Francisco (non-interventional)
Completed
- AL Amyloidosis
- Amyloidosis
- non-interventional
-
South San Francisco, CaliforniaOnline registry
Apr 7, 2019
AL Amyloidosis Trial in Boston (Bortezomib, Melphalan, Neupogen)
Terminated
- AL Amyloidosis
- Bortezomib
- +4 more
-
Boston, MassachusettsBoston Medical Center
Aug 10, 2018
Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone
Unknown status
- Chronic Kidney Disease
- +16 more
- Haploidentical Bone Marrow/Kidney
-
Boston, MassachusettsMassachusetts General Hospital
Mar 21, 2017
AL Amyloidosis Trial in France, Germany, Switzerland
Completed
- AL Amyloidosis
-
Limoges, France
- +3 more
Jul 23, 2015
AL Amyloidosis Trial in Knoxville (Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg))
Completed
- AL Amyloidosis
- Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Sep 17, 2013
AL Amyloidosis Trial in Knoxville (124I-labeled mAb Mu 11-1F4)
Completed
- AL Amyloidosis
- 124I-labeled monoclonal antibody Mu 11-1F4
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Oct 10, 2012